Cav-1−/− show delayed mortality to endotoxemia, associated with a decrease of activation of STAT-1 and expression of iNOS in intestinal epithelial cells, and do not show alterations in intestinal tissue damage and permeability. The gene discussed is CAV1; the disease is serum lipopolysaccharide activity.